Therapeutic strategies targeting post-translational modification of this protein have shown a pivotal potential in the treatment of diabetes, as well as showing the modulation of oxidative stress via SIRT3 has clearly been effective in this multifaceted disease [73]. This evidence concerns the gene SIRT3 and diabetes mellitus.